Sara H Javid, MD
Top Doctor
The Top Doctor award is a peer-nominated award for providers who give exceptional care.
Director, Breast Health Clinic
Seattle Cancer Care Alliance
Seattle Cancer Care Alliance
Associate Professor, Department of Surgery
University of Washington School of Medicine
University of Washington School of Medicine
Clinical expertise
Breast cancer
Breast cancer
Located at
Clinical expertise
Surgical Oncology
Surgical Oncology
Diseases treated
Benign Breast Disease
Ductal Carcinoma in Situ (DCIS)
Lobular Carcinoma in Situ (LCIS)
Phyllodes Breast Tumors
Medical Degree
Harvard University
Harvard University
Residency
Brigham and Women's Hospital
Brigham and Women's Hospital
Fellowship
Massachusetts General Hospital, Breast Surgical Oncology; Brigham and Women's Hospital , Research Fellowship
Massachusetts General Hospital, Breast Surgical Oncology; Brigham and Women's Hospital , Research Fellowship
Board Certification
General Surgery, 2008, 2018, American Board of Surgery
General Surgery, 2008, 2018, American Board of Surgery
Languages
English
Your care team
At SCCA, you receive care from a team of providers with extensive experience in your disease. Your team includes doctors, a team coordinator, a registered nurse, an advanced practice provider and others, based on your needs. You also have access to experts like nutritionists, social workers, acupuncturists, psychiatrists and more who specialize in supporting people with cancer or blood disorders.
Lauren D. Hamman, DNP, ARNP
Advanced Registered Nurse Practitioner
Advanced Practice Provider
Registered nurse (RN)
Your nurse manages your care alongside your physician and assists with care procedures and
treatments.
Team coordinator (TC)
Your team coordinator works closely with you and your physician and serves as your scheduler.
Clinical trials
We make promising new treatments available to you through studies called clinical trials led by SCCA doctors. Many of these trials at SCCA have led to FDA-approved treatments and have improved standards of care globally. Together, you and your doctor can decide if a study is right for you.
Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies
Study No:
NCT02706392
Phase:
Phase I
Study of RP1 Monotherapy and RP1 in Combination With Nivolumab
Study No:
NCT03767348
Phase:
Phase I/II
Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma
Study No:
NCT03422003
Phase:
Phase N/A
Publications
Many of our SCCA physicians conduct ongoing research to improve standards of patient care. Their work is evaluated by other physicians and selected for publication to the United States National Library of Medicine, the largest medical library in the world. See scientific papers this SCCA provider has written.
"Help me figure this out": Qualitative explorations of patient experiences with cancer pathology reports.
Association between the 21-gene recurrence score and isolated locoregional recurrence in stage I-II, hormone receptor-positive breast cancer.